Germany's Bayer to invest $2.2 billion in US pharma site

Economic Times - Oct 3, 2026

Bayer has announced a significant investment of $2.2 billion to establish a new pharmaceutical site in New Albany, Ohio. This project follows over $7 billion in investments by Bayer in US pharmaceutical research and development. The facility aims to focus on critical areas including cancer, heart, and kidney care. It is expected to create around 600 permanent jobs and 1,500 construction jobs during its development.

Read full article
More News
Copyright © 2015 - 2026 The Financial Capital.

All Rights Reserved.

Subscribe Now!

About Us

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.